Opportunity

Federal Register #CMS-10346 and CMS-10453

CMS Requests Public Comment on Proposed Information Collection Activities for Medicare Programs

Buyer

Health and Human Services Department, Centers for Medicare & Medicaid Services, Office of the Secretary

Posted

August 13, 2026

Respond By

October 13, 2026

Identifier

CMS-10346 and CMS-10453

NAICS

541910

This notice from the Centers for Medicare & Medicaid Services (CMS), part of the Department of Health and Human Services, announces a request for public comment on proposed information collection activities under the Paperwork Reduction Act. - Government Buyer: - Department of Health and Human Services (HHS) - Centers for Medicare & Medicaid Services (CMS) - Purpose: - Seeking public input on two information collection activities: - Quality Bonus Payment Appeals (Form CMS-10346, OMB Control No. 0938-1129) - Involves Medicare Advantage (MA) organizations appealing their Quality Bonus Payment status - Medicare Advantage and Prescription Drug Programs: Part C and Part D Explanation of Benefits (Form CMS-10453, OMB Control No. 0938-1228) - Requires organizations to provide written explanations of benefits to enrollees - Affected Entities: - Private sector, including for-profit and not-for-profit institutions - Notable Requirements: - No procurement of products or services is involved - No OEMs or vendors are named - Focus is on collecting feedback to improve the information collection process - Public comments are requested on burden estimates, necessity, utility, and suggestions for improvement

Description

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public under the Paperwork Reduction Act of 1995. The notice invites comments on burden estimates, necessity, utility, and ways to enhance the quality and clarity of the information to be collected. The collections relate to Medicare and Medicaid programs, including Quality Bonus Payment Appeals and Medicare Advantage and Prescription Drug Programs Explanation of Benefits. Comments must be received by October 13, 2026.

View original listing